Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Gihanna Galindez, Julian Matschinske, Tim Rose, et al.
Nature Computational Science (2021) Vol. 1, Iss. 1, pp. 33-41
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Immune-mediated inflammatory disease therapeutics: past, present and future
Iain B. McInnes, Ellen M. Gravallese
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 680-686
Open Access | Times Cited: 209
A critical overview of computational approaches employed for COVID-19 drug discovery
Eugene Muratov, Rommie E. Amaro, Carolina Horta Andrade, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9121-9151
Open Access | Times Cited: 181
Deep generative molecular design reshapes drug discovery
Xiangxiang Zeng, Fei Wang, Yuan Luo, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100794-100794
Open Access | Times Cited: 145
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 140
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Ziaurrehman Tanoli, Adrià Fernández‐Torras, Umut Onur Özcan, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Niclosamide for Covid-19: bridging the gap
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8195-8202
Open Access | Times Cited: 57
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Applications of Artificial Intelligence in Drug Repurposing
Zhaoman Wan, Xinran Sun, Yi Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Structure-based molecular modeling in SAR analysis and lead optimization
Veronika Temml, Zsófia Kutil
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 1431-1444
Open Access | Times Cited: 44
A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 699-721
Open Access | Times Cited: 38
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 17
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
Afsaneh Sadremomtaz, Zayana M. Al-Dahmani, Angel J. Ruiz‐Moreno, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2836-2847
Open Access | Times Cited: 33
Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19
Yi Cong, Toshinori Endo
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 7, pp. 361-371
Open Access | Times Cited: 27
Drug repurposing against SARS-CoV-2 using computational approaches
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 2015-2027
Open Access | Times Cited: 24
Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of Coronavirus SARS-CoV-2
Kateryna Lohachova, Anastasiia S . Sviatenko, Alexander Kyrychenko, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 6
Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies
Francesco Napolitano, Xiaopeng Xu, Xin Gao
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Computational methods directed towards drug repurposing for COVID-19: advantages and limitations
Prem P. Sharma, Meenakshi Bansal, Aaftaab Sethi, et al.
RSC Advances (2021) Vol. 11, Iss. 57, pp. 36181-36198
Open Access | Times Cited: 29
In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
Wallace Chan, Keith M. Olson, Jesse W. Wotring, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges
Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1066-1066
Open Access | Times Cited: 21
A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 78-78
Open Access | Times Cited: 20
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
Agata Blasiak, Anh T. L. Truong, Alexandria Remus, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 20
Favipiravir vs. Deferiprone: Tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2
Nikolay Tzvetkov, Martina I. Peeva, Maya G. Georgieva, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100176-100176
Open Access | Times Cited: 4
Comprehensive applications of the artificial intelligence technology in new drug research and development
Hongyu Chen, Dong Xin Lu, Ziyi Xiao, et al.
Health Information Science and Systems (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 4
COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning
Yang Liu, You Wu, Xiaoke Shen, et al.
Frontiers in Bioinformatics (2021) Vol. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top